RMB Depreciation Reflects Well on SKE's Export of E-cigarettes

Business by 2FIRSTS.ai

Apr.08.2024

RMB Depreciation Reflects Well on SKE's Export of E-cigarettes

Investors inquire about Yinghe Technology's subsidiary Sikary exporting $3.4 billion worth of e-cigarettes in 2023 in foreign currency amid recent RMB depreciation.

Recently, some investors have inquired about Yinghe Technology (300457), asking whether its subsidiary SKE will export 3.4 billion e-cigarettes in 2023 and if the transactions will be settled in foreign currency. With the recent depreciation of the Renminbi, they want to know if the company will benefit from this.

The company responded by stating that SKE mainly settles transactions in US dollars, so the depreciation of the Chinese yuan is beneficial for them.

References:

[1]

Also Read:

[1] Stock Prices of Smoore and Yinghe Plummet after UK Disposable Ban

[2] Yinghe Technology's Major Shareholder Transfers Shares to Subsidiary

[3] Yinghe Technology Achieves Strong Growth in Q3 2023

[4] Yinghe Technology: Sikary Expands Overseas with Pod System Products

#Asia #Open system e-cigarettes #Market #China #Disposable e-cigarettes

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ZYN’s Trademark Dilemma in China | Legal Opinion Submitted to 2Firsts

ZYN faces trademark revocation and enforcement challenges in China. In this legal commentary submitted to 2Firsts, the author examines regulatory gaps, enforcement hurdles, and the high legal risks surrounding nicotine pouch trademarks.

Oct.14

Michigan Senator introduces bill to strengthen regulation of tobacco and nicotine products, amend tax law

The Michigan Senate in the United States proposed Bill No. 582, which aims to strengthen the regulation of tobacco and nicotine products, and violations will face penalties.

Sep.28 by 2FIRSTS.ai

Expert Warns in 2Firsts Op-ed: Proposed COP11 Ban on Nicotine Pouches Would Be a Global Public Health Mistake

As global delegates prepare for COP11, a leaked EU position paper has sparked fresh debate over the future of nicotine pouch regulation. In an exclusive op-ed submitted to 2Firsts, Dr. Nveed Chaudhary, Chair of GINN’s Scientific Committee, argues that banning nicotine pouches would be a profound public health mistake—one that ignores harm reduction science and risks reversing global progress in smoking cessation.

Nov.03

BAT Malaysia Reports Q3 Results: Net Profit Plummets 89.5%, Stock Price Drops 15%

BAT Malaysia's Q3 results show a sharp 89.5% drop in net profit to RM7 million (approximately $150,000 USD), with revenue also falling to RM300 million (approximately $6.4 million USD). The company attributed the decline to new regulatory requirements, including pictorial health warnings and the retail display ban. Its stock dropped 15.25% to RM4.78 (approximately $1.02 USD).